Fundraising FoxGeneVentiv Therapeutics
Raleigh, US · Founded 2020 · Delaware corporation
Find your way into GeneVentiv Therapeutics
Sign up to see every warm intro you have to GeneVentiv Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GeneVentiv Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GeneVentiv Therapeutics is a pre-clinical gene therapy company that identifies, in-licenses, and develops gene therapies for patients with rare and serious diseases. Its programs target hemophilias, including inhibitor patients, and both infantile- and late-onset forms of Pompe disease.
Founders & leadership
RL
Richard LimehouseNamed on SEC filing
DR
Damon RaceNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2022
▶$1.4MraisedAug 2022 · 1 investors · BiotechnologyRule 506(b)
▶$1.4MraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LimehouseDirector
- Damon RaceExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Enliven TherapeuticsEnliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology. Its discovery work combines clinically validated biological targets with differentiated chemistry to develop drugs for unmet medical needs.
GEn1E LifesciencesGen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.
Companies working in the same space as GeneVentiv Therapeutics.
In the news
Frequently asked questions
- What does GeneVentiv Therapeutics do?
- GeneVentiv Therapeutics is a pre-clinical gene therapy company that identifies, in-licenses, and develops gene therapies for patients with rare and serious diseases. Its programs target hemophilias, including inhibitor patients, and both infantile- and late-onset forms of Pompe disease.
- How much funding has GeneVentiv Therapeutics raised?
- GeneVentiv Therapeutics has disclosed $1.4M raised across 1 round.
- Where is GeneVentiv Therapeutics headquartered?
- GeneVentiv Therapeutics is headquartered in Raleigh, US.